Biotech Archives - Page 93 of 795

3 minute read

Scilex Holding Company Announces Publication In Anesthesiology Journal Of Results From An Investigator-Initiated Research Study Using ZTlido For The Treatment Of Chronic Neck Pain

February 20, 10:16 AM

The lifetime prevalence of neck pain in the adult population is estimated to range from 14.2% to 71% with a mean of 48.5%.2 There are currently no approved medical treatments for neck pain in the U.S.The study was a

SCLX

1 minute read

Omeros Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use In Nine Patients With Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

By Benzinga Newsdesk

February 20, 10:15 AM

Omeros Corporation (NASDAQ:OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy

OMER

1 minute read

RedHill’s Published Data Shows That Opaganib Protects Against Radiation-Induced Lung Inflammation And Fibrosis

By Benzinga Newsdesk

February 20, 10:07 AM

The data, published in the International Journal of Molecular Sciences, demonstrate that opaganib significantly improved long-term survival in an in vivo model of lung damage following exposure to ionizing

GILD

4 minute read

ARS Pharma Announces Topline Results From Repeat Dosing Study Of neffy Under Nasal Allergen Challenge Conditions, Readies Data For Response To FDA’s Complete Response Letter

By Benzinga Newsdesk

February 20, 10:03 AM

Repeat doses of neffy under nasal allergen challenge demonstrate a pharmacokinetic profile greater than or similar to injection, and a pharmacodynamic profile greater than injection Company believes completion of

SPRY

2 minute read

Avidity Biosciences Receives FDA Rare Pediatric Disease Designation For AOC 1044 For Treatment Of Duchenne Muscular Dystrophy In People With Mutations Amenable To Exon 44 Skipping

By Benzinga Newsdesk

February 20, 10:01 AM

Avidity Biosciences, Inc. (NASDAQ:RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the U.S. Food

RNA

3 minute read

Teva Presents New Data Supporting Safety, Tolerability And Target Engagement Of Anti-TL1A Antibody At The 2024 ECCO Annual Meeting

By Benzinga Newsdesk

February 20, 9:55 AM

Results demonstrate rapid and sustained suppression of free TL1A, confirming target engagement of anti-TL1A (TEV-'574)1Anti-TL1A (TEV-'574) was shown to be safe and well-tolerated, with a low incidence of antidrug

SNY

2 minute read

Why AstraZeneca Stock Is Trading Higher Tuesday

By Vandana Singh

February 20, 9:54 AM

FDA greenlights AstraZeneca's Tagrisso combo for advanced EGFRm NSCLC. FLAURA2 Phase 3 trial results reveal a 38% reduction in progression risk with Tagrisso plus chemo, outperforming monotherapy. AstraZeneca's datopotamab deruxtecan awaits FDA decision in Q4 2024 for nonsquamous NSCLC.

AZN

2 minute read

Charles River Collaborates With Pluristyx, Expanding Its Portfolio Of Human Pluripotent Stem Cells

By Benzinga Newsdesk

February 20, 9:45 AM

The addition of ES cells and iPSCs will enhance Charles River's portfolio of powerful research tools supporting acceleration of therapeutic development.Charles River Laboratories International, Inc. (NYSE:CRL) today

CRL

2 minute read

WuXi Advanced Therapies Receives FDA Approval To Manufacture Iovance’s AMTAGVI For Advanced Melanoma

By Benzinga Newsdesk

February 20, 9:35 AM

AMTAGVI is the first and only one-time, individualized T cell therapy to receive U.S. FDA approval for a solid tumor cancer.PHILADELPHIA, Feb. 20, 2024 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly

IOVA

2 minute read

Masimo And UCHealth Announce A Clinical Monitoring Partnership To Improve Care With Telehealth

By Benzinga Newsdesk

February 20, 9:31 AM

Masimo (NASDAQ:MASI), a leading global provider of medical technology and automation solutions, and UCHealth, a nationally recognized network of hospitals, clinics, and providers based in Colorado, announced today that

MASI